Vistusertib
| CAS No. | 1009298-59-2 | Cat. No. | BCP05748 |
| Name | Vistusertib | ||
| Synonyms | AZD 2014; AZD-2014; AZD2014; | ||
| Formula | C25H30N6O3 | M. Wt | 462.54 |
| Description | Vistusertib, also known as AZD2014, is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor AZD2014 inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR, a serine/threonine kinase that is upregulated in a variety of tumors, plays an important role downstream in the PI3K/Akt/mTOR signaling pathway. | ||
| Related Products | AZD2014（Vistusertib sulfate） | ||
| Pathways | PI3K/Akt/mTOR | ||
| Targets | mTOR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.